Retrospective analysis of complete remission in cases with advanced non-small cell lung cancer

Retrospective analysis of complete remission in cases with advanced non-small cell lung cancer - Retrospective analysis of complete remission in cases with advanced non-small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037078

Enrollment

443

Registered

2019-06-18

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stage III and IV non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study eligibility criteria for patients were as follows: stage III or IV (The International Association for the Study of Lung Cancer: IASLC 8th edition of the TNM classification for lung cancer), histologically or cytologically confirmed NSCLC, and first chemotherapy or EGFR-TKI administration had been initiated between 1st Mar 2004 and 30th Apr 2011.

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
The primary outcome of interest is the overall survival of all eligible NSCLC patients.	—

Secondary

Measure	Time frame
The secondary endpoints are patient characteristics, tumor characteristics, and treatment contents and modalities in long-term survivors, whose overall survival exceeded 3 years, and complete remission patients.	—

Countries

Japan

Contacts

Public ContactTakuya Aoki

Tokai University School of Medicine Respiratory Division, Department of Internal Medicine

aokitaku@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results